skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Appendix A: Key to Acronyms

General Terms

(Last updated: May 1, 2014; last reviewed: May 1, 2014)

General Terms
Abbreviation
Full Name
ACTG
AIDS
ALT
ART
ART-CC
ARV
AST
AUC
AV
AWP
bDNA
BID
BMD
BMI
BUN
cap
CAPD
CBC
CCB
CD4
CDC
CI
CKD
AIDS Clinical Trials Group
acquired immune deficiency syndrome
alanine aminotransferase
antiretroviral therapy
ART Cohort Collaboration
antiretroviral
aspartate aminotransferase
area under the curve
atrioventricular
average wholesale price
branched DNA
twice daily
bone mineral density
body mass index
blood urea nitrogen
capsule
chronic ambulatory peritoneal dialysis
complete blood count
calcium channel blocker
CD4 T lymphocyte
Centers for Disease Control and Prevention 
confidence interval
chronic kidney disease 
Cmax
maximum plasma concentration
CME
continuing medical education
Cmin
minimum plasma concentration
CMV
CNICS
CNS
COC
CPK
CrCl
CSF
CVD
CYP
D/M
D:A:D
DILI
DM
DMPA
DOT
DR
DXA
EBV
EC
ECG
EI
EIA
FDA
FI
GHB
GI
HAD
HAV
HBeAg
HBsAg
HBV
HCV
HD
HDL
HELLP
HHS
HHV
HHV-8
HIV
HIV-1
HIV-2
HIVAN
HLA
HPV
HR
HRSA
hsCRP
HSR
HTLV
HTLV-1
HTLV-2
IAS-USA
IC
IDU
IFN-γ
IGRA
IL-6 
IND 
INH
inj
INR
INSTI
IQ 
IRB 
IRIS
IUD
IV 
LDL
LTBI
MAC 
MDMA
mDOT
MDR
MDRD 
MHC 
MI
msec 
MSM
MTB 
NA-ACCORD 
NIH 
NNRTI 
NRTI 
OAR 
OARAC 
OI 
PAH 
PCP
PDE5
PegIFN
p-gp
PI
PI/r
PK
PMTCT
PNS
PO 
PPI 
PR 
PrEP 
PT
q(n)d
q(n)h
QTc 
RT 
RT-PCR 
SCr
SJS
soln
SPT 
STD
SVR
SWP
t½ 
tab
TAM
TB 
TCA
TDM
TEN 
TG
the Panel 
TID
TST
UDP 
UGT
UGT1A1 
ULN
VPA
WBC 
WHO
WITS 
XDR
XR
cytomegalovirus
Centers for AIDS Research Network of Integrated Clinical Systems
central nervous system
combined oral contraceptives
creatine phosphokinase 
creatinine clearance
cerebrospinal fluid
cardiovascular disease
cytochrome P
dual or mixed (tropic)
Data Collection on Adverse Events of Anti-HIV Drugs Study
drug-induced liver injury
diabetes mellitus
depot medroxyprogesterone acetate
directly observed therapy
delayed release
dual-energy x-ray absorptiometry
Epstein-Barr virus
enteric coated
electrocardiogram
entry inhibitor
enzyme immunoassay
Food and Drug Administration
fusion inhibitor
gamma-hydroxybutyrate
gastrointestinal
HIV-associated dementia
hepatitis A virus
hepatitis B e antigen
hepatitis B surface antigen
hepatitis B virus 
hepatitis C virus
hemodialysis
high-density lipoprotein
hemolysis, elevated liver enzymes, low platelet count (syndrome)
Department of Health and Human Services  
human herpes virus
human herpes virus-8
human immunodeficiency virus
human immunodeficiency virus type 1
human immunodeficiency virus type 2
HIV-associated nephropathy
human leukocyte antigen
human papilloma virus
hazard ratio
Health Resource Services Administration
high-sensitivity C-reactive protein
hypersensitivity reaction
human T-cell leukemia virus
human T-cell leukemia virus type 1
human T-cell leukemia virus type 2
International Antiviral Society-USA
inhibitory concentration
injection drug user
interferon-gamma
interferon-gamma release assay
interleukin-6
investigational new drug
isoniazid
injection
international normalized ratio
integrase strand transfer inhibitor
inhibitory quotient
Institutional Review Board 
immune reconstitution inflammatory syndrome
intrauterine device
Intravenous 
low-density lipoprotein
latent tuberculosis infection
Mycobacterium avium complex
methylenedioxymethamphetamine
modified directly observed therapy
multidrug-resistant
modification of diet in renal disease (equation)
major histocompatability complex
myocardial infarction
milliseconds
men who have sex with men
Mycobacterium tuberculosis
The North American AIDS Cohort Collaboration on Research and Design
National Institutes of Health
non-nucleoside reverse transcriptase inhibitor
nucleoside reverse transcriptase inhibitor
Office of AIDS Research
Office of AIDS Research Advisory Council
opportunistic infection
pulmonary arterial hypertension
Pneumocystis jiroveci pneumonia
phosphodiesterase type 5
peginterferon
p-glycoprotein
protease inhibitor
ritonavir-boosted PI
pharmacokinetic
prevention of mother-to-child transmission
peripheral nervous system
orally
proton pump inhibitor
protease (gene)
pre-exposure HIV prophylaxis 
prothrombin time
every (n) days
every (n) hours
QT corrected for heart rate
reverse transcriptase (gene)
reverse transcriptase-polymerase chain reaction
Serum creatinine
Stevens-Johnson syndrome
solution
skin patch test
sexually transmitted disease
sustained virologic response
suggested wholesale price
half-life
tablet
thymidine analogue mutation
tuberculosis
tricyclic antidepressant
therapeutic drug monitoring
toxic epidermal necrosis 
triglyceride
Panel on Antiretroviral Guidelines for Adults and Adolescents
three times daily
tuberculin skin test
uridine diphosphate
uridine diphosphate gluconyltransferase
uridine diphosphate glucuronosyltransferase 1A1
upper limit of normal
valproic acid
white blood cell
World Health Organization
Women and Infants Transmission Study
extensively drug-resistant
extended release

Back to Top